Immutep Ltd Adr Stock Analysis

Immutep Stock Analysis Notes

The book value of the company was currently reported as 0.12. The company recorded a loss per share of 0.21. Immutep Ltd ADR last dividend was issued on the 28th of December 2016. The entity had 3:10 split on the 28th of December 2016. Immutep Limited, a biotechnology company, engages in the research and development of pharmaceutical products. Immutep Limited was incorporated in 1987 and is headquartered in Sydney, Australia. Immutep operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. To learn more about Immutep Ltd ADR call Marc Voigt at 61 2 8315 7003 or check out https://www.immutep.com.

Immutep Ltd ADR Investment Alerts

Immutep Ltd ADR Upcoming and Recent Events

Immutep Largest EPS Surprises

View All Earnings Estimates

Immutep Stock Institutional Investors

Note, although Immutep's institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Immutep Market Capitalization

The company currently falls under 'Small-Cap' category with a current market capitalization of 249.79 M.

Immutep Profitablity

Management Efficiency

Immutep Ltd ADR has return on total asset (ROA) of (0.2035) % which means that it has lost $0.2035 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.3045) %, meaning that it created substantial loss on money invested by shareholders. Immutep's management efficiency ratios could be used to measure how well Immutep manages its routine affairs as well as how well it operates its assets and liabilities. As of 07/22/2025, Return On Tangible Assets is likely to drop to -0.21. In addition to that, Return On Capital Employed is likely to drop to -0.44. At this time, Immutep's Total Current Liabilities is relatively stable compared to the past year. As of 07/22/2025, Liabilities And Stockholders Equity is likely to grow to about 243.4 M, while Non Current Liabilities Total is likely to drop slightly above 1.7 M.

Technical Drivers

As of the 22nd of July, Immutep retains the Downside Deviation of 4.48, market risk adjusted performance of 0.3385, and Risk Adjusted Performance of 0.0613. Immutep technical analysis makes it possible for you to employ historical prices and volume momentum with the intention to determine a pattern that calculates the direction of the firm's future prices.

Immutep Ltd ADR Price Movement Analysis

Immutep Outstanding Bonds

Immutep Predictive Daily Indicators

Immutep Forecast Models

Immutep's time-series forecasting models are one of many Immutep's stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Immutep's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

Stock analysis is the technique used by a trader or investor to examine and evaluate how Immutep prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Immutep shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Immutep. By using and applying Immutep Stock analysis, traders can create a robust methodology for identifying Immutep entry and exit points for their positions.

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Immutep analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Immutep analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.

Immutep Ltd ADR stock analysis indicators help investors evaluate how Immutep stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading Immutep shares will generate the highest return on investment. By understating and applying Immutep stock analysis, traders can identify Immutep position entry and exit signals to maximize returns.

When running Immutep's price analysis, check to measure Immutep's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Immutep is operating at the current time. Most of Immutep's value examination focuses on studying past and present price action to predict the probability of Immutep's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Immutep's price. Additionally, you may evaluate how the addition of Immutep to your portfolios can decrease your overall portfolio volatility.